Table 1.

Demographics and Baseline Characteristics of the Intention to Treat Population

Parameter	SPMC with bisacodyl (n=181)	Conventional 4-L PEG (n=184)	p-value*
Male sex	94 (51.9)	100 (54.4)	0.644
Age, yr	53.5±10.7	53.8±10.4	0.788
20–64	154 (85.1)	154 (83.7)	0.715
≥65	27 (14.9)	30 (16.3)
Indication for colonoscopy			0.195
Symptom evaluation	38 (21)	37 (20.1)
Screening	68 (37.6)	79 (42.9)
Surveillance	50 (27.6)	34 (18.5)
For endoscopic treatment	25 (13.8)	34 (18.5)

Data are presented as mean±SD or number (%).

SPMC, sodium picosulfate with magnesium citrate; PEG, polyethylene glycol.

^*p-values were calculated using Student t-test or Pearson chi-square test, as appropriate.